News

This content was published in the EU4MD update released on 30.06.2021. This update also presents a section on partnerships, annoucements, studies, upcoming events, and a research corner.

The Council of the EU (Foreign Affairs) approved on 21 June the EU Drugs Action Plan for 2021–2025.

Today, the EU drugs agency (EMCDDA) publishes its European Drug Report 2021: Trends and Developments, the latest annual review of the drug situation in Europe (1).

Since early 2020, the COVID-19 pandemic has had a dramatic impact on the way in which we live. Countries in Europe, and around the world, have had to introduce unprecedented measures to protect public health.

How has the COVID-19 pandemic affected drug use and supply? What drugs are causing the most concern today? What are the latest trends in drug production and trafficking?

In the last few weeks, three US states have legalised cannabis for recreational purposes, all via the legislature and not via public ballots.

In the third in its series of rapid ‘trendspotter’ studies, the EMCDDA explores the impact of COVID-19 on the drug situation and responses to it.

This content was published in the EU4MD update released on 16.04.2021. This update also presents a section on partnerships, annoucements, studies, upcoming events, and a research corner.

European Commissioner for Home Affairs Ylva Johansson paid her first visit to the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) today during a day of events relating to the fight against organised crime.